Cleveland State University has hired a former Cleveland Clinic and University of Maryland cardiovascular researcher as the new dean of its College of Sciences and Health Professions. Meredith Bond, who most recently chaired the department of physiology at the University of Maryland’s School of Medicine, is scheduled to begin her tenure at CSU on July […]
A medical education partnership between Cleveland State University and Northeast Ohio Medical University (NEOMED) is set to kick off this fall with the goal of producing more primary care doctors in urban neighborhoods. Students in the program will begin at Cleveland State (CSU) and then move on to clinical study at NEOMED, which until recently […]
The Austen BioInnovation Institute in Akron has received a $2.6 million Ohio Third Frontier grant for biomedical sensor research and commercialization. The grant is from the revamped Wright Center for Sensor Systems Engineering at Cleveland State University.
US Endoscopy, the endoscopy device design and manufacturing company in Mentor, has released the Entrada colonic overtube, which offers more control during colonoscopy in patients with tortuous sigmoid looping.
Gov. Ted Strickland and Ohio Board of Regents Chancellor Eric Fingerhut donned their high-tech marketing hats Friday, touting the state's leadership in biomedical and health care innovation by announcing centers of excellence at 14 universities.
Dr. Michael Kalafatis was working on an experiment in the Cleveland State University Chemistry Department involving blood coagulation when he discovered that a substance he was using killed cancer cells without damaging surrounding tissue.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
CWRU medical school Dean Dr. Pamela B. Davis and CSU bioethics law professor Dena S. Davis are members of a nine-member Working Group for Human Embryonic Stem Cell Eligibility Review.
The National Institutes of Health has released $1,156,739 of economic stimulus money for medical research and education to seven institutions and hospitals in Ohio.
